Laboratory findings in SARS-CoV-2 infections: State of the art

SUMMARY OBJECTIVE The scientific community is constantly assessing the clinical and laboratory manifestations of COVID-19 in the organism. In view of the fragmentation of the large amount of information, knowledge gaps in relation to laboratory markers, and scarcity of papers in Portuguese, we propose a Literature review on laboratory changes observed in patients infected with SARS-CoV-2. METHODS Analysis of articles published between December 2019 and May 2020 on the PubMed and SciELO databases. The articles were identified, filtered, and evaluated based on the approach to the subject, language, and impact. Then, the articles were subjected to a thorough reading, in full, by 4 (four) independent researchers. RESULTS Leukopenia and lymphopenia were included in most studies, even in case definitions. Platelet count and platelet-lymphocyte ratio, at peak platelet, were associated with advanced age and longer hospital stay. Eosinopenia showed a sensitivity of 74.7% and specificity of 68.7% and, together with increased CRP, these are one of the future prospects for screening for disease. A high level of procalcitonin may indicate bacterial co-infection, leading to a worse prognosis. COVID-19 manifests itself with increased levels of many inflammatory markers such as IL-1, IL-2, IL-6, IL-7, IL-12, IP10, IFN-γ, MIP1A, MCP1, GSCF, TNF-α, and MCP1/CCL2, as well as LDH, ESR, D-dimer, CK, ALT, and AST. CONCLUSION There is a need for further studies on the new SARS-CoV-2. So far, there is no consensus regarding laboratory findings and their usefulness, whether as a prognostic marker, mortality, or disease severity.

Saved in:
Bibliographic Details
Main Authors: Pereira,Miguel Augusto Martins, Barros,Isabella Carolina de Almeida, Jacob,Ana Luiza Veríssimo, Assis,Mayara Lopes de, Kanaan,Salim, Kang,Hye Chung
Format: Digital revista
Language:English
Published: Associação Médica Brasileira 2020
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302020000801152
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0104-42302020000801152
record_format ojs
spelling oai:scielo:S0104-423020200008011522020-09-09Laboratory findings in SARS-CoV-2 infections: State of the artPereira,Miguel Augusto MartinsBarros,Isabella Carolina de AlmeidaJacob,Ana Luiza VeríssimoAssis,Mayara Lopes deKanaan,SalimKang,Hye Chung Coronavirus Infections Betacoronavirus Blood Cell Count Leukocyte Count SUMMARY OBJECTIVE The scientific community is constantly assessing the clinical and laboratory manifestations of COVID-19 in the organism. In view of the fragmentation of the large amount of information, knowledge gaps in relation to laboratory markers, and scarcity of papers in Portuguese, we propose a Literature review on laboratory changes observed in patients infected with SARS-CoV-2. METHODS Analysis of articles published between December 2019 and May 2020 on the PubMed and SciELO databases. The articles were identified, filtered, and evaluated based on the approach to the subject, language, and impact. Then, the articles were subjected to a thorough reading, in full, by 4 (four) independent researchers. RESULTS Leukopenia and lymphopenia were included in most studies, even in case definitions. Platelet count and platelet-lymphocyte ratio, at peak platelet, were associated with advanced age and longer hospital stay. Eosinopenia showed a sensitivity of 74.7% and specificity of 68.7% and, together with increased CRP, these are one of the future prospects for screening for disease. A high level of procalcitonin may indicate bacterial co-infection, leading to a worse prognosis. COVID-19 manifests itself with increased levels of many inflammatory markers such as IL-1, IL-2, IL-6, IL-7, IL-12, IP10, IFN-γ, MIP1A, MCP1, GSCF, TNF-α, and MCP1/CCL2, as well as LDH, ESR, D-dimer, CK, ALT, and AST. CONCLUSION There is a need for further studies on the new SARS-CoV-2. So far, there is no consensus regarding laboratory findings and their usefulness, whether as a prognostic marker, mortality, or disease severity.info:eu-repo/semantics/openAccessAssociação Médica BrasileiraRevista da Associação Médica Brasileira v.66 n.8 20202020-08-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302020000801152en10.1590/1806-9282.66.8.1152
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Pereira,Miguel Augusto Martins
Barros,Isabella Carolina de Almeida
Jacob,Ana Luiza Veríssimo
Assis,Mayara Lopes de
Kanaan,Salim
Kang,Hye Chung
spellingShingle Pereira,Miguel Augusto Martins
Barros,Isabella Carolina de Almeida
Jacob,Ana Luiza Veríssimo
Assis,Mayara Lopes de
Kanaan,Salim
Kang,Hye Chung
Laboratory findings in SARS-CoV-2 infections: State of the art
author_facet Pereira,Miguel Augusto Martins
Barros,Isabella Carolina de Almeida
Jacob,Ana Luiza Veríssimo
Assis,Mayara Lopes de
Kanaan,Salim
Kang,Hye Chung
author_sort Pereira,Miguel Augusto Martins
title Laboratory findings in SARS-CoV-2 infections: State of the art
title_short Laboratory findings in SARS-CoV-2 infections: State of the art
title_full Laboratory findings in SARS-CoV-2 infections: State of the art
title_fullStr Laboratory findings in SARS-CoV-2 infections: State of the art
title_full_unstemmed Laboratory findings in SARS-CoV-2 infections: State of the art
title_sort laboratory findings in sars-cov-2 infections: state of the art
description SUMMARY OBJECTIVE The scientific community is constantly assessing the clinical and laboratory manifestations of COVID-19 in the organism. In view of the fragmentation of the large amount of information, knowledge gaps in relation to laboratory markers, and scarcity of papers in Portuguese, we propose a Literature review on laboratory changes observed in patients infected with SARS-CoV-2. METHODS Analysis of articles published between December 2019 and May 2020 on the PubMed and SciELO databases. The articles were identified, filtered, and evaluated based on the approach to the subject, language, and impact. Then, the articles were subjected to a thorough reading, in full, by 4 (four) independent researchers. RESULTS Leukopenia and lymphopenia were included in most studies, even in case definitions. Platelet count and platelet-lymphocyte ratio, at peak platelet, were associated with advanced age and longer hospital stay. Eosinopenia showed a sensitivity of 74.7% and specificity of 68.7% and, together with increased CRP, these are one of the future prospects for screening for disease. A high level of procalcitonin may indicate bacterial co-infection, leading to a worse prognosis. COVID-19 manifests itself with increased levels of many inflammatory markers such as IL-1, IL-2, IL-6, IL-7, IL-12, IP10, IFN-γ, MIP1A, MCP1, GSCF, TNF-α, and MCP1/CCL2, as well as LDH, ESR, D-dimer, CK, ALT, and AST. CONCLUSION There is a need for further studies on the new SARS-CoV-2. So far, there is no consensus regarding laboratory findings and their usefulness, whether as a prognostic marker, mortality, or disease severity.
publisher Associação Médica Brasileira
publishDate 2020
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302020000801152
work_keys_str_mv AT pereiramiguelaugustomartins laboratoryfindingsinsarscov2infectionsstateoftheart
AT barrosisabellacarolinadealmeida laboratoryfindingsinsarscov2infectionsstateoftheart
AT jacobanaluizaverissimo laboratoryfindingsinsarscov2infectionsstateoftheart
AT assismayaralopesde laboratoryfindingsinsarscov2infectionsstateoftheart
AT kanaansalim laboratoryfindingsinsarscov2infectionsstateoftheart
AT kanghyechung laboratoryfindingsinsarscov2infectionsstateoftheart
_version_ 1756410077007314944